NDC 54766-093 – Ridaura

Auranofin 3 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC54766-093

Product details

Brand name
Ridaura
Generic name
Auranofin
Labeler
Sebela Pharmaceuticals Inc.
Dosage form
Capsule
Route
Oral
Marketing category
NDA · NDA018689
Marketed since
December 15, 2016
Marketing end
October 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Ridaura →

Package NDC codes (1)

Package NDCDescriptionSince
54766-093-0660 CAPSULE in 1 BOTTLE (54766-093-06)Dec 15, 2016